Kymera Therapeutics

KYMR | NASDAQ | 0 Followers
$44.48 -1.61% -$0.73
Follow
Overview Metrics Financials
Loading...

Fair Price

$64.32
Overvalued by 75.2%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Kymera Therapeutics is a U.S.-based biotechnology company that specializes in the development of therapeutics aimed at protein modulation using advanced protein degradation technologies. The company uses an innovative approach to treating diseases by focusing on selectively degrading faulty proteins in the body rather than blocking them. Kymera Therapeutics focuses on developing drugs for the treatment of oncology, immunology, and rare diseases, with its technology holding the potential to significantly change the way many serious health issues are treated.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade